For years, weight loss advice has been all about diet trends, fitness challenges, and social-media hacks. Yet physicians who ...

A whopping 85% of men experience significantly thinning hair by age 50, and two-thirds experience noticeable hair loss by age ...

Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...

Novo Nordisk stock fell over 16% Monday after it said its next-generation weight loss drug didn't meet its primary target.

Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug Administration (FDA) recently approved a daily pill form of Wegovy, making it the ...

For the best results, medications like Ozempic and Zepbound should be combined with exercise and healthy eating habits.

Weight loss pills may seem like a quick-fix solution when you want to drop pounds, but they come with significant risks. Learn more here.

Feb 12 (Reuters) - Eli Lilly (LLY.N), opens new tab had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday, ahead of an expected decision ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health (HIMS.N), opens new tab on Thursday began offering a much cheaper $49 compounded version of Novo Nordisk's (NOVOb.CO), opens ...

Novo Nordisk said it filed a federal lawsuit Feb. 9 against telehealth provider Hims & Hers, alleging the company infringed on Novo's patent by selling versions of its blockbuster weight-loss drug ...

Eli Lilly and Company (NYSE: LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulatory filing on Thursday. This significant ...